Latest News
A recent study published in Journal of the American Medical Association (JAMA) Network Open found that key diabetes medicines can likely be manufactured at costs far below their current market prices. The economic evaluation, led by Yale postdoctoral associate Melissa Barber, PhD in conjunction with collaborators from Doctors Without Borders (Médecins Sans Frontières (MSF)), calculated the manufacturing costs for insulins, sodium-glucose cotransporter 2 inhibitors (SGLT2Is), and glucagon-like peptide 1 agonists (GLP1As) – all widely used diabetes medicines.
- April 03, 2024
A recent collaborative study conducted by Yale researchers sought to apply these methods towards developing a framework for measuring equitable readmissions to the hospital, and to identify hospitals that have equitable rates of readmission.
- April 01, 2024
Yale faculty and trainees will present clinical research at the upcoming American College of Cardiology Scientific Meeting.
- December 14, 2023
The Department of Internal Medicine is pleased to welcome the following new staff, faculty, postdoctoral/postgraduate associates, and postdoctoral fellows who joined the team in November 2023.
- October 12, 2023
The Department of Internal Medicine is pleased to welcome the following new staff, faculty, postdoctoral/postgraduate associates, and postdoctoral/postgraduate fellows who joined the team in September 2023.
- October 05, 2023
An FDA advisory committee found that an OTC decongestant, phenylephrine, works no better than a placebo at relieving congestion. Yale researchers discuss how drugs with insufficient evidence make it to market.
- September 11, 2023
The Yale Open Data Access (YODA) Project, a pioneering initiative to promote open science and facilitate sharing of clinical trial research data, has reached the milestone of supporting more than 100 publications.
- July 05, 2023
The Yale-Mayo Clinic FDA Center of Excellence in Regulatory Science and Innovation (CERSI) was recently renewed with an award of up to $50M for five years from the U.S. Food and Drug Administration (FDA). The partnership between Yale School of Medicine (YSM) and Mayo Clinic provides academic scientists the opportunity to perform regulatory science research, training, and education in collaboration with the FDA.
- May 24, 2023Source: ENDPOINTSNEWS
Reshma Ramachandran, MD, MPP, MHS, named by Endpoint News, the leading pharm/biotech trade news organization, as one of the 20 under 40 "next generation" of biotech leaders!
- May 11, 2023
Discoveries & Impact highlights select scientific discoveries across the Department of Internal Medicine...